Business Description
Sunmax Biotechnology Co Ltd
NAICS : 325412
SIC : 2834
ISIN : TW0004728001
Description
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.53 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 0.18 | |||||
| Interest Coverage | 304.15 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 12.91 | |||||
| Beneish M-Score | -1.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.4 | |||||
| 3-Year EBITDA Growth Rate | 38 | |||||
| 3-Year EPS without NRI Growth Rate | 37.2 | |||||
| 3-Year FCF Growth Rate | 42.2 | |||||
| 3-Year Book Growth Rate | 17.1 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.7 | |||||
| 9-Day RSI | 43.43 | |||||
| 14-Day RSI | 49.48 | |||||
| 6-1 Month Momentum % | 11.35 | |||||
| 12-1 Month Momentum % | -18.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.36 | |||||
| Quick Ratio | 2.15 | |||||
| Cash Ratio | 2.1 | |||||
| Days Inventory | 105.76 | |||||
| Days Sales Outstanding | 0.18 | |||||
| Days Payable | 14.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.28 | |||||
| Dividend Payout Ratio | 0.83 | |||||
| 3-Year Dividend Growth Rate | 85 | |||||
| Forward Dividend Yield % | 4.28 | |||||
| 5-Year Yield-on-Cost % | 92.5 | |||||
| Shareholder Yield % | 3.76 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 83.18 | |||||
| Operating Margin % | 52.98 | |||||
| Net Margin % | 37.05 | |||||
| FCF Margin % | 43.7 | |||||
| ROE % | 47.82 | |||||
| ROA % | 30.67 | |||||
| ROIC % | 51.12 | |||||
| ROC (Joel Greenblatt) % | 108.44 | |||||
| ROCE % | 60.86 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.39 | |||||
| PE Ratio without NRI | 19.39 | |||||
| Shiller PE Ratio | 62.31 | |||||
| Price-to-Owner-Earnings | 16.78 | |||||
| PEG Ratio | 0.32 | |||||
| PS Ratio | 7.19 | |||||
| PB Ratio | 8.5 | |||||
| Price-to-Tangible-Book | 8.53 | |||||
| Price-to-Free-Cash-Flow | 16.44 | |||||
| Price-to-Operating-Cash-Flow | 14.3 | |||||
| EV-to-EBIT | 12.42 | |||||
| EV-to-EBITDA | 11.5 | |||||
| EV-to-Revenue | 6.71 | |||||
| EV-to-FCF | 15.31 | |||||
| Price-to-Projected-FCF | 2.18 | |||||
| Price-to-Median-PS-Value | 0.88 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.78 | |||||
| Price-to-Graham-Number | 2.71 | |||||
| Price-to-Net-Current-Asset-Value | 35.04 | |||||
| Price-to-Net-Cash | 52.98 | |||||
| Earnings Yield (Greenblatt) % | 8.05 | |||||
| FCF Yield % | 6.1 | |||||
| Forward Rate of Return (Yacktman) % | 22.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sunmax Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,688.987 | ||
| EPS (TTM) (NT$) | 11.47 | ||
| Beta | -0.15 | ||
| Volatility % | 100 | ||
| 14-Day RSI | 49.48 | ||
| 14-Day ATR (NT$) | 6.447618 | ||
| 20-Day SMA (NT$) | 228.15 | ||
| 12-1 Month Momentum % | -18.38 | ||
| 52-Week Range (NT$) | 175 - 300 | ||
| Shares Outstanding (Mil) | 54.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sunmax Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sunmax Biotechnology Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sunmax Biotechnology Co Ltd Frequently Asked Questions
What is Sunmax Biotechnology Co Ltd(ROCO:4728)'s stock price today?
The current price of ROCO:4728 is NT$222.50. The 52 week high of ROCO:4728 is NT$300.00 and 52 week low is NT$175.00.
When is next earnings date of Sunmax Biotechnology Co Ltd(ROCO:4728)?
The next earnings date of Sunmax Biotechnology Co Ltd(ROCO:4728) is .
Does Sunmax Biotechnology Co Ltd(ROCO:4728) pay dividends? If so, how much?
The Dividend Yield %  of Sunmax Biotechnology Co Ltd(ROCO:4728) is 4.28% (As of Today), Highest Dividend Payout Ratio of Sunmax Biotechnology Co Ltd(ROCO:4728) was 1.62. The lowest was 0.21. And the median was 0.45. The  Forward Dividend Yield % of Sunmax Biotechnology Co Ltd(ROCO:4728) is 4.28%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers